Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL158756 | 0.84 | LMNA (0.36) | LMNAAOC3 | |
| SCHEMBL3585938 | 0.82 | ALDH1A1 (0.40) | LMNAAOC3 | |
| SCHEMBL1145324 | 0.81 | CSNK1E (0.41) | LMNA | |
| SCHEMBL4070717 | 0.81 | LMNA (0.31) | LMNA | |
| SCHEMBL28166688 | 0.81 | LMNA (0.31) | LMNA | |
| SCHEMBL28166447 | 0.81 | LMNA (0.31) | LMNA | |
| SCHEMBL3598843 | 0.80 | AOC3 (0.33) | LMNATSHRAOC3 | |
| SCHEMBL3590952 | 0.80 | CSNK1E (0.43) | — | |
| SCHEMBL3594986 | 0.80 | CSNK1E (0.43) | — | |
| SCHEMBL3584428 | 0.80 | CSNK1E (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017034377-A1 | PYRIDOPYRIMIDINONE COMPOUNDS FOR MODULATING THE CATALYTIC ACTIVITY OF HISTONE LYSINE DEMETHYLASES (KDMS) | DONG-A ST CO., LTD. (KR) | 2017-03-02 | — | — | WO | claimed |
| US-20170057955-A1 | Pyridopyrimidinone Compounds for Modulating the Catalytic Activity of Histone Lysine Demethylases (KDMs) | DONG-A ST CO., LTD. (KR) | 2017-03-02 | — | — | US | claimed |
| EP-2229942-B1 | 2-Aryl-propionic acids and pharmaceutical compositions containing them | DOMPE SPA (IT) | 2012-08-29 | — | — | EP | claimed |
| EP-3517553-B1 | CATALYST COMPONENT FOR USE IN OLEFIN POLYMERIZATION, CATALYST, AND APPLICATIONS THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2023-11-08 | — | — | EP | disclosed |
| CN-112067718-B | Establishment method of muskiness rheumatalgia-relieving plaster volatile component fingerprint, standard fingerprint and application thereof | 重庆希尔安药业有限公司 | 2022-07-29 | — | — | CN | disclosed |
| US-11325994-B2 | Catalyst component for olefin polymerization, catalyst, and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2022-05-10 | — | — | US | disclosed |
| CN-112067718-A | Establishment method of muskiness rheumatalgia-relieving plaster volatile component fingerprint, standard fingerprint and application thereof | 重庆希尔安药业有限公司 | 2020-12-11 | — | — | CN | disclosed |
| US-10662268-B2 | Catalyst component for olefin polymerization, catalyst, and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2020-05-26 | — | — | US | disclosed |
| US-20190256623-A1 | CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, CATALYST, AND USE THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2019-08-22 | — | — | US | disclosed |
| EP-3517555-A1 | CATALYST COMPONENT FOR USE IN OLEFIN POLYMERIZATION, CATALYST, AND APPLICATIONS THEREOF | China Petroleum&Chemical Corporation (CN) | 2019-07-31 | — | — | EP | disclosed |
| EP-3517553-A1 | CATALYST COMPONENT FOR USE IN OLEFIN POLYMERIZATION, CATALYST, AND APPLICATIONS THEREOF | China Petroleum&Chemical Corporation (CN) | 2019-07-31 | — | — | EP | disclosed |
| WO-2000006176-A1 | AMIDOPHOSPHATE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2000-02-10 | — | — | WO | disclosed |
| WO-2000006539-A1 | ALKENYL SULPHONAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2000-02-10 | — | — | WO | disclosed |
| WO-2000006537-A1 | N-SUBSTITUTED SULFONAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2000-02-10 | — | — | WO | disclosed |
| EP-0976744-A1 | Amide, carbamate, and urea derivatives having glutamate receptor function potentiating activity | ELI LILLY AND COMPANY (US) | 2000-02-02 | — | — | EP | disclosed |
| WO-1999057101-A1 | PYRAZOLE DERIVATIVES AS P-38 MAP KINASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 1999-11-11 | — | — | WO | disclosed |
| CN-1040105-C | Aminoketone derivatives and use thereof | MITZUI TOATSU CHEMICALS INC (JP) | 1998-10-07 | — | — | CN | disclosed |
| EP-0860428-A2 | Sulphonamide derivatives | ELI LILLY AND COMPANY (US) | 1998-08-26 | — | — | EP | disclosed |
| WO-1998033496-A1 | SULPHONAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 1998-08-06 | — | — | WO | disclosed |
| US-4520095-A | STABLE CYAN DYE FOR COLOR DIFFUSION TRANSFER IN SILVER HALIDE EMULSION-CONTAINING FILMS | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1985-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170057955-A1 | Pyridopyrimidinone Compounds for Modulating the Catalytic Activity of Histone Lysine Demethylases (KDMs) | KDM1B, KDM1A, KDM3B | LMNA 1606/4885TRPA1 4677/4885TSHR 4360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.